News & Events
Press Releases
- December 9, 2008
- ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical Company
- November 13, 2008
- ProMetic reports business highlights and Third Quarter Financial Results
- November 12, 2008
- ProMetic announces date and time of Third Quarter Financials and Conference Call/Webcast
- November 6, 2008
- ProMetic to present at Rodman & Renshaw’s Tenth Annual Healthcare Conference
- October 16, 2008
- ProMetic provides business update
- October 7, 2008
- ProMetic presents at Prion 2008
- October 2, 2008
- Letter to Shareholders
- September 30, 2008
- ProMetic to present at BioContact Québec 2008
- September 12, 2008
- ProMetic to present at Merriman Curhan Ford’s Investor Summit 2008 on September 16th
- September 4, 2008
- Abraxis and ProMetic enter license agreements for up to $295 M US for four biopharmaceuticals
- August 14, 2008
- ProMetic reports business highlights and Second Quarter financial results
- August 5, 2008
- ProMetic reaches understanding for commercialization of several biopharmaceutical products and strategic investment
- July 11, 2008
- ProMetic group announces appointment of Bruce Pritchard as Chief Financial Officer
- June 25, 2008
- ProMetic further confirms performance of prion capture resin at the Recovery of Biological Products Conference
- June 16, 2008
- Poster from European Hematology Association - PBI-1402 increases hemoglobin level and red blood cell count in chemotherapy-induced anemia
- June 14, 2008
- Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association
- June 10, 2008
- Part 2 - PRDT technology in Octaplas(R) process - ISBT - Macao SAR, China
- June 10, 2008
- Part 1 - PRDT technology in Octaplas(R) process - ISBT - Macao SAR, China
- June 9, 2008
- ProMetic announces Octapharma publication of PRDT’s prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion Meeting in Macao SAR, China
- June 5, 2008
- Official signing ceremony for WIBP strategic alliance
- June 3, 2008
- ProMetic Life Sciences Inc. raises C$5 M
- May 15, 2008
- ProMetic reports business highlights and First Quarter financial results
- May 1, 2008
- ProMetic provides information for its Annual and Special Meeting of Shareholders
- April 23, 2008
- Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial
- April 16, 2008
- Prometic presents preclinical data for prostate and pancreatic cancer at the AACR Meeting
- April 9, 2008
- ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
- April 7, 2008
- ProMetic closes previously announced financing for a total of C$ 5,050,000
- April 4, 2008
- ProMetic to present at the American Chemical Society
- March 28, 2008
- ProMetic Life Sciences Inc. to raise up to C$5 M
- March 28, 2008
- ProMetic announce highlights and year end financials for 2007
- March 18, 2008
- ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
- March 12, 2008
- ProMetic announces strategic alliance agreement with Wuhan Institute of Biological Products for the implementation of plasma fractionation technology in China
- March 6, 2008
- ProMetic reports continued positive data in PBI-1402 Phase II trial in chemotherapy-induced anemia
- February 25, 2008
- ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
- February 6, 2008
- ProMetic provides business update - over $35 million worth of business secured in January
- January 23, 2008
- ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
- January 18, 2008
- ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
- January 7, 2008
- ProMetic reports that PRDT technology amplifies sensitivity for BSE detection in cattle